Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Protagonist Therapeutics
Biotech
At ASCO, execs see chance to ‘rewrite textbooks’ in cancer care
Although ASCO's CEO started the meeting with a warning about Trump's proposed budget cuts, the mood didn't carry over for most attendees.
Gabrielle Masson
Jun 2, 2025 9:45am
J&J, Protagonist's oral psoriasis prospect bests BMS' Sotyktu
Mar 10, 2025 7:30am
Takeda's $300M bet on Protagonist's blood cancer drug pays off
Mar 3, 2025 8:45am
J&J, Protagonist's oral psoriasis prospect scores in phase 3s
Nov 19, 2024 11:44am
Takeda plays Protagonist, paying $300M for blood disease pact
Jan 31, 2024 5:41pm
Protagonist, J&J oral psoriasis efficacy data spur phase 3 plans
Jul 4, 2023 2:50am
